Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
GoldHaven Files NI 43-101 Technical Report for the District-Scale Magno Polymetallic Project, Cassiar District, British Columbia
-
Gymboree and Marchesa Introduce MARCHESA MINI X GYMBOREE, a Collection of Elevated Occasion-Wear
-
Join Off The Hook’s Exclusive Live Investor Webinar and Q&A Session on March 11
-
1847 Holdings Signs LOI to Acquire 40-Year Construction Contractor with $29 Million Backlog
-
Reliance Global Group Schedules Fourth Quarter 2025 Financial Results and Business Update Conference Call
-
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
-
Gymboree and Marchesa Introduce MARCHESA MINI X GYMBOREE, a Collection of Elevated Occasion-Wear
-
DirectBooking Technology Co., Ltd. Announces Regained Compliance with Nasdaq Minimum Bid Price Requirement
-
Odysight.ai Partners with XP Services for First US Flight Testing of its AI-Predictive Maintenance System on UH-60 Helicopter
-
SunCar Forecasting Preliminary Unaudited 2025 Revenue of $498 million, Strong Q4 Growth of 24%, Second Half 2025 Profitability, and 20% Revenue Growth in 2026
-
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
-
Blue Hat Interactive Entertainment Technology Announces Share Repurchase Program
-
AMC Robotics Highlights AI Quadruped Robot at Tokyo Security Show 2026
-
Join Off The Hook’s Exclusive Live Investor Webinar and Q&A Session on March 11
-
Form 8.3 LondonMetric Property Plc
-
Form 8.3 British Land Co plc
-
Form 8.3 Augmentum Fintech Plc
-
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
-
HIGHCO: SHAREHOLDING
-
Luotea PLC - Managers' Transactions: Antti Niitynpää
-
Alpha Modus Secures Settlement in Ongoing AI Retail Technology Patent Enforcement Efforts
-
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
-
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
-
Blaze Pizza Celebrates Pi Day 2026 with Fan-Favorite $3.14 Buy One, Get One Deal
-
White Lodging Named 2026 Gallup Exceptional Workplace Award Winner
-
Brunswick Exploration Announces Upsized Non-Brokered Life Private Placement
-
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization
-
Cohen & Company Reports Fourth Quarter & Full Year 2025 Financial Results
-
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
-
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
-
Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026
-
Artelo Biosciences Announces Reverse Stock Split
-
Anathapindika Shines Spotlight on World Sleep Day
-
Anathapindika Spotlight Shines on Rare Disease Day (and How Detoxification Can Help)
-
Hurco Reports First Quarter Results for Fiscal Year 2026
-
EagleNXT Announces Strategic Investment in Leading Israeli Precision Loitering Munition Innovator
-
Prenetics Authorizes $40 Million Share Repurchase Program
-
Signing Day Sports Special Stockholder Meeting to Consider and Vote on Proposed Business Combination with BlockchAIn Digital Infrastructure to Be Held March 13, 2026
-
NMI Holdings, Inc. to Participate at the RBC Global Financial Institutions Conference on March 11th, 2026
-
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026
-
Cohen & Company Reports Fourth Quarter & Full Year 2025 Financial Results
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
C.M. Advises VisionWave of Joint Venture Initiative in India with Major Industrial Manufacturing Group
-
CORRECTION vol2: Eesti Energia Group Unaudited Results for 2025
-
VEON and JazzWorld Advance Pakistan’s Digital Financial Future with Acquisition of TPL Insurance
-
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization
-
Virtuix Rings the Nasdaq Closing Bell Celebrating its Listing on the Nasdaq Global Market
-
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
Consolidated Lithium Metals Provides Update on Kwyjibo Rare Earth Project
